How Should Practitioners Evaluate Lower Face Aesthetic Candidates For Neurotoxin Vs. Laser Resurfacing? Match Treatment To The Anatomical Cause For Optimal Results.

The deciding question is whether the visible problem is caused by muscle activity or by skin and soft-tissue change. Neurotoxin injections are appropriate when lower-face lines or contours are produced mainly by hyperfunctional muscles, such as mentalis dimpling, upper-lip lines, or a gummy smile. Laser resurfacing and other energy-based devices are more appropriate for static wrinkles, photoaging, superficial laxity, acne scarring, and deteriorating skin texture. Many patients have both mechanisms and may benefit from a conservative combination rather than choosing one modality exclusively.

Match the treatment to the anatomical cause: neurotoxin softens excessive muscle contraction, while resurfacing and energy-based tightening address dermal quality, superficial laxity, and photoaging. Neither modality replaces structural volume correction or surgery when those are the primary problems.

Start With the Cause of Lower-Face Aging

Separate dynamic lines from static lines

Ask whether the line appears or deepens during facial movement and softens at rest. A wrinkle that is primarily movement-dependent suggests muscle activity and may respond to neurotoxin.

Static rhytids remain visible when the face is relaxed. These are more consistent with photodamage, collagen loss, or established skin folding and may require resurfacing or another skin-tightening approach.

Identify the anatomical target

Lower-face width and contour are influenced by mandibular bone, masseter muscle volume, subcutaneous fat, and skin laxity. A treatment decision should follow the dominant cause rather than the visual impression of a “wide” or “heavy” lower face.

Neurotoxin can reduce selected muscle activity. It cannot remove excess fat, tighten substantially lax skin, restore lost volume, or alter mandibular bone structure.

Use objective assessment alongside consultation

Facial analysis and skin-testing systems can help document soft-tissue volume, fat distribution, dermal elasticity, and surface damage. Baseline imaging is especially useful when the patient’s concern is broader than a single line or muscle.

Objective findings should support, not replace, a clinical examination and a discussion of the patient’s priorities.

When Neurotoxin Is the Better Fit

Treat hyperfunctional lower-face muscles

Neurotoxin is primarily suited to lines and contours created by excessive contraction. Relevant examples include chin dimpling from mentalis activity, upper-lip lines, and gummy smiles.

The intended result is usually muscle softening, not complete immobilization. This is particularly important in the lower face, where small changes in muscle function can affect speech, smiling, playing wind instruments, and other activities.

Use conservative dosing and clear endpoints

Lower facial muscles may be more functionally sensitive than upper facial muscles. Practitioners should therefore use conservative dosing, precise placement, and a defined assessment of the desired degree of softening.

A patient seeking correction of loose, photoaged skin is not an appropriate candidate for escalating neurotoxin doses. More toxin cannot compensate for a skin-quality problem.

Recognize what neurotoxin cannot correct

Neurotoxin does not treat static photoaging, diffuse surface texture deterioration, skin laxity, or volume loss. It also does not correct structural folds that are primarily caused by tissue descent or deeper anatomical change.

When these findings dominate the consultation, neurotoxin alone is unlikely to meet the patient’s expectations.

When Energy-Based Treatment Is the Better Fit

Treat static wrinkles and surface photodamage

Laser resurfacing is better suited to wrinkles visible at rest, superficial perioral lines, uneven texture, shallow acne scars, and photoaged skin. Its purpose is to stimulate tissue remodeling and improve the broader skin surface.

This makes resurfacing appropriate when the concern extends across an area rather than following the action of one specific muscle.

Evaluate superficial laxity separately from major structural sagging

Energy-based tightening systems, including HIFU and microneedle RF, may be considered when subcutaneous tissue contribution and dermal laxity are important components of lower-face broadening or jawline blunting.

Marked structural sagging or pronounced folds may exceed the predictable capabilities of superficial resurfacing and tightening. Such patients may require evaluation for surgical lifting rather than repeated device treatments.

Match the device to severity and downtime

Traditional ablative resurfacing can provide stronger correction for severe rhytids but is generally most suitable for carefully selected lighter phototypes. Fractional ablative and non-ablative approaches allow the practitioner to adjust treatment depth, density, and downtime to the degree of photodamage or scarring.

For darker phototypes and off-face treatment areas, conservative density and appropriate risk counseling are important because dyspigmentation and post-inflammatory complications are greater concerns.

Screen the Candidate Before Resurfacing

Assess phototype and pigment risk

Fitzpatrick phototype is one part of the risk assessment, not a substitute for individualized planning. Lighter phototypes may be more straightforward candidates for traditional ablative treatment, while darker phototypes often require modified settings, alternative technologies, and careful pigment-risk counseling.

The statement that darker skin is categorically unsuitable for all resurfacing is too broad. Fractional and non-ablative strategies may be considered across phototypes when the device, settings, indication, and operator experience are appropriate.

Review wrinkle and scar morphology

Superficial rhytids and shallow acne scars are generally more compatible with resurfacing. Dynamic rhytids should first prompt evaluation of muscle activity.

Deep ice-pick scars, substantial structural folds, and severe tissue descent may require other treatments or combinations. Resurfacing should not be presented as a universal solution for every scar or fold.

Check healing and medication history

Recent isotretinoin use is a relevant safety consideration because impaired sebaceous gland function may compromise reepithelialization. The supplementary reference identifies use within the previous 12 months as an unfavorable factor for resurfacing; practitioners should apply current local guidance and product-specific contraindications when making the final decision.

A complete history should also include prior procedures, pigmentary reactions, wound-healing problems, active skin disease, and the patient’s ability to follow aftercare instructions.

When a Combination Approach Is Reasonable

Address separate mechanisms with separate tools

A patient may have both movement-related chin dimpling and static perioral lines. In that situation, low-dose neurotoxin can address the dynamic component while resurfacing or skin tightening addresses texture and laxity.

The combination should be designed around distinct treatment targets. It should not be used to justify excessive toxin dosing when the major concern is loose or photoaged skin.

Sequence treatment around function and recovery

Because lower-face neurotoxin can affect speech and expression, practitioners should plan treatment conservatively and set expectations about the degree of change. Energy-based procedures should be selected with the patient’s healing capacity, pain tolerance, and acceptable downtime in mind.

The treatment plan should specify which finding each modality is expected to improve. This makes later assessment more objective and reduces the risk that an unavoidable limitation is interpreted as treatment failure.

Establish realistic expectations

Energy-based treatments can produce variable responses. Some patients experience substantial improvement, while others see a more modest change.

Consultation should explain expected benefit, likely number of sessions, downtime, and the possibility of incomplete correction before treatment begins. These limitations belong in pretreatment consent, not only in discussions after an unexpected result.

Understanding the Trade-offs

Neurotoxin has functional risks

Too much lower-face neurotoxin or imprecise placement can cause unwanted weakness. Possible consequences include altered enunciation, an abnormal smile, and difficulty with activities that depend on fine oral-muscle control.

The risk is managed through conservative treatment goals, appropriate dosing, accurate anatomical targeting, and follow-up rather than by treating the entire lower face aggressively.

Resurfacing has recovery and pigment risks

Ablative resurfacing can provide stronger remodeling but involves more recovery and greater procedural burden. Pigmentary change, especially in higher-risk phototypes, must be addressed during device selection and consent.

Non-ablative and lower-density fractional approaches may reduce downtime or pigment risk, but their results can be subtler and may require multiple sessions.

Neither modality corrects every structural problem

Neither neurotoxin nor resurfacing reliably replaces deficient deep volume, changes bone structure, removes substantial subcutaneous fat in every case, or corrects major tissue descent. Fillers, fat-directed treatments, surgical consultation, or observation may be more appropriate depending on the underlying anatomy.

Treating the wrong layer is the central failure mode: muscle treatment for lax skin and surface treatment for major structural sagging will produce limited value.

How to Apply This to Your Assessment

Begin with an open-ended consultation, such as asking what brings the patient in and what change they hope to see. Combine that narrative with relaxed and animated examination, palpation, facial analysis, skin assessment, and documentation of baseline findings.

If your primary focus is dynamic lines or muscle-driven contour: Consider conservative, targeted neurotoxin treatment after confirming that muscle activity is the dominant cause and discussing possible functional effects.
If your primary focus is static wrinkles, photoaging, texture, or shallow scars: Evaluate the patient for laser resurfacing or another energy-based modality matched to phototype, severity, and downtime tolerance.
If your primary focus is superficial lower-face laxity or soft-tissue broadening: Assess fat distribution and dermal elasticity, then consider an appropriate tightening technology such as HIFU or microneedle RF when the laxity is within its expected treatment range.
If your primary focus is major sagging, deep folds, bone structure, or volume loss: Do not rely on neurotoxin or resurfacing alone; evaluate whether surgical, volumizing, or other structural treatment is required.
If your primary focus is comprehensive rejuvenation: Treat each mechanism separately, using low-dose neurotoxin for selected dynamic findings and energy-based treatment for skin quality, while setting expectations about variable response and possible multiple sessions.

The most reliable candidate selection comes from identifying the tissue layer responsible for the visible problem and choosing the least aggressive modality that directly addresses it.

Summary Table:

Feature	Neurotoxin	Energy-Based Resurfacing/Tightening
Primary Indication	Dynamic lines, muscle-driven contours (e.g., mentalis dimpling, gummy smile)	Static wrinkles, photoaging, superficial laxity, acne scars, texture issues
Mechanism	Blocks nerve signals to relax hyperfunctional muscles	Stimulates collagen remodeling and tissue tightening
Best Candidates	Healthy individuals with muscle-induced lines, no significant skin laxity	Those with photodamage, static wrinkles, shallow scars, mild laxity; varied phototypes (with appropriate settings)
Downtime	Minimal, no downtime	Varies: ablative (longer), non-ablative/fractional (shorter)
Risks	Functional impairment if overdosed (speech, smile)	Pigment changes, especially in darker skin; infection; scarring
Limitations	Not for static lines, laxity, or volume loss	Not for dynamic lines or major structural sagging
Combination	Can be combined with resurfacing to address both dynamic and static components	Often combined with neurotoxin for comprehensive rejuvenation

Ready to refine your lower-face aesthetic protocols? Partner with BELIS to access state-of-the-art laser and energy-based platforms (Diode, Alexandrite, CO2, Nd:YAG, Pico, HIFU, Microneedle RF, and more) trusted by clinics and premium salons. Our OEM/ODM support, certified quality, and reliable supply chain empower you to deliver tailored cosmetic solutions. Contact us today to elevate your practice and meet your patients' needs with precision.